• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    CHIEF EXECUTIVE OFFICER Blair Patrick T covered exercise/tax liability with 5,054 shares, decreasing direct ownership by 0.71% to 709,072 units (SEC Form 4)

    12/2/25 4:29:44 PM ET
    $INNV
    Medical/Nursing Services
    Health Care
    Get the next $INNV alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    BLAIR PATRICK T

    (Last) (First) (Middle)
    8950 E. LOWRY BOULEVARD

    (Street)
    DENVER CO 80230

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    InnovAge Holding Corp. [ INNV ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    CHIEF EXECUTIVE OFFICER
    3. Date of Earliest Transaction (Month/Day/Year)
    12/01/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock, $0.001 par value 12/01/2025 F(1) 5,054 D $5.47 709,072 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Represents shares withheld to satisfy the Reporting Person's tax obligations in connection with the vesting and settlement of restricted stock units.
    Remarks:
    /s/ Nicole D'Amato, by Power of Attorney 12/02/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $INNV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $INNV

    DatePrice TargetRatingAnalyst
    9/18/2025$5.00Underweight
    Analyst
    12/17/2024$5.00Neutral → Underweight
    Analyst
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    5/16/2022$6.00 → $5.00Outperform → Neutral
    Robert W. Baird
    4/20/2022$4.00 → $5.00Neutral → Underweight
    Piper Sandler
    1/10/2022$8.00 → $5.00Neutral
    Citigroup
    12/28/2021$15.00 → $4.00Buy → Neutral
    Goldman Sachs
    12/27/2021$22.00 → $6.50Overweight → Equal-Weight
    Barclays
    More analyst ratings

    $INNV
    SEC Filings

    View All

    InnovAge Holding Corp. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - InnovAge Holding Corp. (0001834376) (Filer)

    5/18/26 8:02:06 AM ET
    $INNV
    Medical/Nursing Services
    Health Care

    InnovAge Holding Corp. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - InnovAge Holding Corp. (0001834376) (Filer)

    5/12/26 4:33:46 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    InnovAge Holding Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - InnovAge Holding Corp. (0001834376) (Filer)

    5/5/26 4:09:40 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    $INNV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Traynor Sean

    3 - InnovAge Holding Corp. (0001834376) (Issuer)

    1/30/26 4:15:41 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    SEC Form 3 filed by new insider Mahesh Pavithra

    3 - InnovAge Holding Corp. (0001834376) (Issuer)

    1/30/26 4:14:58 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    CHIEF EXECUTIVE OFFICER Blair Patrick T covered exercise/tax liability with 5,054 shares, decreasing direct ownership by 0.71% to 709,072 units (SEC Form 4)

    4 - InnovAge Holding Corp. (0001834376) (Issuer)

    12/2/25 4:29:44 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    $INNV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Zoretic Richard C bought $173,307 worth of shares (42,715 units at $4.06), increasing direct ownership by 166% to 68,494 units (SEC Form 4)

    4 - InnovAge Holding Corp. (0001834376) (Issuer)

    5/30/25 5:08:25 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    Director Zoretic Richard C bought $12,308 worth of shares (3,045 units at $4.04), increasing direct ownership by 13% to 25,779 units (SEC Form 4)

    4 - InnovAge Holding Corp. (0001834376) (Issuer)

    5/23/25 4:31:41 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    Director Zoretic Richard C bought $12,317 worth of shares (2,893 units at $4.26), increasing direct ownership by 15% to 22,734 units (SEC Form 4)

    4 - InnovAge Holding Corp. (0001834376) (Issuer)

    5/20/25 8:57:01 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    $INNV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    InnovAge Appoints Jennifer Browne as President and Chief Operating Officer

    DENVER, May 12, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced that Jennifer Browne has been appointed President and Chief Operating Officer, effective June 8, 2026. Ms. Browne brings deep experience leading complex, multi-state healthcare organizations operating under value-based care models. She has a strong track record of improving performance across operations, clinical quality, compliance, and financial outcomes while scaling services to reach mor

    5/12/26 4:30:00 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    InnovAge Announces Financial Results for the Fiscal Third Quarter Ended March 31, 2026

    DENVER, May 05, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced financial results for its fiscal third quarter ended March 31, 2026. We delivered a solid third quarter, reflecting continued improvement in operating execution and financial performance," said Patrick Blair, Chief Executive Officer of InnovAge. "These results are being driven by stronger performance across our centers and the benefits of the investments we've made over the past several year

    5/5/26 4:05:00 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    InnovAge to Announce Fiscal Third Quarter 2026 Financial Results and Host Conference Call Tuesday, May 5, 2026

    DENVER, April 21, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced it will release its 2026 fiscal third quarter financial results on Tuesday, May 5, 2026, after market close. In conjunction, the Company will host a conference call to review the results at 5 p.m. E.T. on the same day. Conference Call DetailsA live audio webcast of the call will be available on the Company's website, https://investor.innovage.com/. A replay of the call will be availabl

    4/21/26 8:00:00 AM ET
    $INNV
    Medical/Nursing Services
    Health Care

    $INNV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Analyst resumed coverage on InnovAge with a new price target

    Analyst resumed coverage of InnovAge with a rating of Underweight and set a new price target of $5.00

    9/18/25 8:43:47 AM ET
    $INNV
    Medical/Nursing Services
    Health Care

    InnovAge downgraded by Analyst with a new price target

    Analyst downgraded InnovAge from Neutral to Underweight and set a new price target of $5.00

    12/17/24 8:06:24 AM ET
    $INNV
    Medical/Nursing Services
    Health Care

    KeyBanc Capital Markets initiated coverage on InnovAge

    KeyBanc Capital Markets initiated coverage of InnovAge with a rating of Sector Weight

    10/11/24 7:47:55 AM ET
    $INNV
    Medical/Nursing Services
    Health Care

    $INNV
    Leadership Updates

    Live Leadership Updates

    View All

    InnovAge Appoints Jennifer Browne as President and Chief Operating Officer

    DENVER, May 12, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced that Jennifer Browne has been appointed President and Chief Operating Officer, effective June 8, 2026. Ms. Browne brings deep experience leading complex, multi-state healthcare organizations operating under value-based care models. She has a strong track record of improving performance across operations, clinical quality, compliance, and financial outcomes while scaling services to reach mor

    5/12/26 4:30:00 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    InnovAge Appoints Dr. Paul Taheri as Chief Medical Officer

    DENVER, Nov. 03, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), appoints Paul Taheri, MD, MBA as its Chief Medical Officer, effective November 3, 2025. Dr. Paul Taheri, a board-certified trauma surgeon, brings more than 30 years of healthcare leadership to InnovAge. He has served as a Clinical Quality Advisor to Welsh, Carson, Anderson & Stowe, a role he has held since 2019. Dr. Taheri previously served as CEO and Deputy Dean for Clinical Affairs at the Yale School of

    11/3/25 4:05:00 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    InnovAge Appoints Meredith Delk as Executive Vice President and Chief Administrative Officer

    DENVER, Sept. 23, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), appoints Meredith Delk as its Executive Vice President and Chief Administrative Officer, effective September 30, 2025. Meredith Delk brings over 20 years of healthcare leadership experience to InnovAge, and until recently led one of the largest Medicaid PBMs in the country. In this newly created role at InnovAge, Delk will lead InnovAge's Pharmacy Solutions, Behavioral Health, Home Health, and Therapy ser

    9/23/25 8:00:00 AM ET
    $INNV
    Medical/Nursing Services
    Health Care

    $INNV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by InnovAge Holding Corp.

    SC 13G/A - InnovAge Holding Corp. (0001834376) (Subject)

    11/13/24 7:44:57 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    $INNV
    Financials

    Live finance-specific insights

    View All

    InnovAge Announces Financial Results for the Fiscal Third Quarter Ended March 31, 2026

    DENVER, May 05, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced financial results for its fiscal third quarter ended March 31, 2026. We delivered a solid third quarter, reflecting continued improvement in operating execution and financial performance," said Patrick Blair, Chief Executive Officer of InnovAge. "These results are being driven by stronger performance across our centers and the benefits of the investments we've made over the past several year

    5/5/26 4:05:00 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    InnovAge to Announce Fiscal Third Quarter 2026 Financial Results and Host Conference Call Tuesday, May 5, 2026

    DENVER, April 21, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced it will release its 2026 fiscal third quarter financial results on Tuesday, May 5, 2026, after market close. In conjunction, the Company will host a conference call to review the results at 5 p.m. E.T. on the same day. Conference Call DetailsA live audio webcast of the call will be available on the Company's website, https://investor.innovage.com/. A replay of the call will be availabl

    4/21/26 8:00:00 AM ET
    $INNV
    Medical/Nursing Services
    Health Care

    InnovAge Announces Financial Results for the Fiscal Second Quarter Ended December 31, 2025

    DENVER, Feb. 03, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced financial results for its fiscal second quarter ended December 31, 2025. "InnovAge delivered strong operating and financial results this quarter, reflecting continued progress in building a scalable, high-quality PACE platform," said Patrick Blair, CEO. "Our performance is rooted in disciplined execution and a care model that prioritizes clinical outcomes, participant experience, and respon

    2/3/26 4:05:00 PM ET
    $INNV
    Medical/Nursing Services
    Health Care